KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects - Concepedia

Concepedia

Publication | Closed Access

KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects

35

Citations

14

References

2016

Year

S.-E. W. Huskey, Chunqi Zhu, Andreas Fredenhagen, Jürgen Kühnöl, Alexandre Luneau, Miao Zhang, Fan Yang, J. P. Jain, Gangadhar Sunkara, J. B. Mangold,

Drug Metabolism and Disposition

References

	Year	Citations

Page 1